Nearly 350 million individuals worldwide suffer from arthritis today, an autoimmune disorder in which the immune system attacks the body, resulting in inflammation and stiffness of the joints. Since late 1998, ENBREL has been prescribed by Rheumatologists in order to reduce these signs and symptoms of arthritis, as well as prevent further damage of the joints. In order to make this prescription medication appear as a desirable solution to doctors and patients alike, Amgen Inc., the producer of ENBREL, uses rhetorical devices and rhetorical fallacies to their advantage online. The efficacious use of rhetorical devices, including ethos, logos, and pathos, as well as rhetorical fallacies such as bandwagon, stacking the deck, and false authority,
